Therefore, S100A12 is used as a subclinical indicator of inflammation or microbial infection, and the increase in the blood concentration of S100A12 protein has been associated with Type 2 diabetes, atherosclerosis-related inflammation, and tumorigenic processes50–52. The gene discussed is S100A12; the disease is type 2 diabetes mellitus.